Skip to content
Alternative Cost-Saving Strategies for Innovative Treatments: Will Medicaid Enter the Value-Based Pricing Market?
2019 FDA Approvals: A Year in Review
Biosimilairs, FDA, FDA Approvals, Magellan Health, Magellan RX, Magellan Rx Management, New Drugs, Novel drugs, Orphan Drugs, Trend Alert
“Drug Shortages: Root Causes and Potential Solutions” – Insight from a FDA Task Force
21st Century Measles Outbreak
Going Beyond Traditional Benefits: Healthcare Systems Begin to Address Social Determinants of Health
Accountable Care Organizations, CMS, Magellan, Magellan Health, Magellan RX, Medicaid, Medicare, Medicare Advantage, SDOH, Trend Alert, Trend Alerts
